{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Environmental toxicology", "Mycotoxin", "Polycystic ovary", "Rat", "Zearalenone"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30055260", "DateCompleted": {"Year": "2018", "Month": "12", "Day": "11"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "07", "Day": "26"}], "Language": ["eng"], "ELocationID": ["10.1016/j.toxicon.2018.07.022", "S0041-0101(18)30325-8"], "Journal": {"ISSN": "1879-3150", "JournalIssue": {"Volume": "154", "PubDate": {"Year": "2018", "Month": "Nov"}}, "Title": "Toxicon : official journal of the International Society on Toxinology", "ISOAbbreviation": "Toxicon"}, "ArticleTitle": "Molecular and biochemical evidence on the role of zearalenone in rat polycystic ovary.", "Pagination": {"StartPage": "7", "EndPage": "14", "MedlinePgn": "7-14"}, "Abstract": {"AbstractText": ["Globally, food and animal feed contamination with mycotoxins is one of the most important challenges affecting human health. Zearalenone is a non-steroidal mycotoxin with estrogen-like activity that has been reported to induce reproductive dysfunctions including polycystic ovary in women. The aim of this study was to assess the possible impact of prolonged low dose zearalenone (0.1\u202fmg/kg b.w.) exposure to increase the risk of developing polycystic ovary in rats. We found that zearalenone increases the plasma insulin, glucose, testosterone, progesterone and luteinizing hormone levels, while the plasma estradiol level was reduced. Zearalenone also incited tumor necrosis factor-\u03b1 and the secreted frizzled-related protein-4 expressions. Histological examination showed atresia of follicles in the treated group. It is concluded that zearalenone intoxication intensely manipulates the plasma hormonal factors and the level of gene expressions related to the polycystic ovary in rats, thus increases the risk of its progression."], "CopyrightInformation": "Copyright \u00a9 2018 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Abbasian", "ForeName": "Nakisa", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran; Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Baeeri", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran; Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Navaei-Nigjeh", "ForeName": "Mona", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Hosseini", "ForeName": "Rohollah", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran. Electronic address: Mohammad.Abdollahi@UToronto.Ca."}], "LastName": "Abdollahi", "ForeName": "Mohammad", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Toxicon", "NlmUniqueID": "1307333", "ISSNLinking": "0041-0101"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Estrogens"}, {"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Sfrp4 protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "3XMK78S47O", "NameOfSubstance": "Testosterone"}, {"RegistryNumber": "4G7DS2Q64Y", "NameOfSubstance": "Progesterone"}, {"RegistryNumber": "4TI98Z838E", "NameOfSubstance": "Estradiol"}, {"RegistryNumber": "5W827M159J", "NameOfSubstance": "Zearalenone"}, {"RegistryNumber": "9002-67-9", "NameOfSubstance": "Luteinizing Hormone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Blood Glucose"}, {"QualifierName": ["blood"], "DescriptorName": "Estradiol"}, {"QualifierName": ["blood"], "DescriptorName": "Estrogens"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["blood"], "DescriptorName": "Insulin"}, {"QualifierName": ["blood"], "DescriptorName": "Luteinizing Hormone"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Ovarian Follicle"}, {"QualifierName": ["blood", "chemically induced", "pathology"], "DescriptorName": "Polycystic Ovary Syndrome"}, {"QualifierName": ["blood"], "DescriptorName": "Progesterone"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins"}, {"QualifierName": [], "DescriptorName": "Random Allocation"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["blood"], "DescriptorName": "Testosterone"}, {"QualifierName": [], "DescriptorName": "Toxicity Tests, Chronic"}, {"QualifierName": ["blood"], "DescriptorName": "Tumor Necrosis Factor-alpha"}, {"QualifierName": ["administration & dosage", "toxicity"], "DescriptorName": "Zearalenone"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "4", "Day": "24"}, {"Year": "2018", "Month": "7", "Day": "15"}, {"Year": "2018", "Month": "7", "Day": "22"}, {"Year": "2018", "Month": "7", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "29", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30055260", "10.1016/j.toxicon.2018.07.022", "S0041-0101(18)30325-8"]}}]}